v3.26.1
Interim Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities        
Net loss and comprehensive loss $ (426,253) $ 265,776 $ (17,629,675) $ (24,621,514)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 568,141 535,237 2,308,400 1,900,819
Share based compensation 489,467 591,462 2,685,964 1,301,213
Disposal of equipment     202,493
Change in deferred taxes     (116,385) (128,395)
Loss on impairment of goodwill and intangible assets     2,337,264 2,414,485
Change in fair value of contingent consideration     (855,000)
Lease cost, net of repayment 3,420 11,355 (4,259) 34,387
Amortization and extinguishment of debt discounts 212,217 248,456 993,024 6,750,863
Change in fair value of derivative liability 390,405 (3,538,440) (8,934,632) 6,113,485
Unrealized loss (gain) on crypto asset 25,309 39,266 99,061 (20,376)
Loss on extinguishment of convertible debentures     13,878,098 2,935,028
Loss on impairment of prepaid assets and notes receivable     246,899
Changes in operating assets and liabilities        
Accounts receivable, net (1,041,388) (494,238) 801,890 135,516
Prepaid expenses and deposits (754,368) (946,659) 116,089 232,925
Deferred costs and other current assets     (1,800) (507,186)
Inventory (234,276) (721,538) 821,605 (934,056)
Other assets 4,436 10,584 326,080 (76,385)
Accounts payable and other accrued liabilities 410,941 1,320,132 (511,252) (363,768)
Holdback liability     (160,000)
Related party payables (142,867) 224,728 108,354 767,508
Uncertain tax positions 889,817 617,667 2,545,279 3,421,953
Net cash provided by (used in) operating activities 395,001 (1,836,212) (336,895) (1,049,106)
Cash Flows from Investing Activities        
Equipment purchase (494,839) (162,075) (642,014) (5,919,341)
Proceeds from sale of crypto currency     403,622
Investment in intangible assets     (510,831) (346,777)
Net cash used in investing activities (494,839) (162,075) (749,223) (6,266,118)
Cash Flows from Financing Activities        
Issuance of common shares     1,350,707 2,277,759
Financing arrangements     241,898
Proceeds from issuance of notes payable     749,630 1,325,574
Issuance of preferred and common shares 4,500,000    
Repayment of notes (249,912) (22,097) (1,159,133) (469,829)
Repayment of related party contingent consideration (235,000)    
Proceeds from issuance of related party note payable 204,000 249,900
Cash repayments of related party notes payable (350,000) (396,000)
Net cash provided by financing activities 3,665,088 181,903 545,204 3,625,302
Net increase (decrease) in Cash 3,565,250 (1,816,384) (540,914) (3,689,922)
Effect of foreign exchange translation (343) (343) 7,314
Cash, beginning of period 2,190,722 2,731,979 2,731,979 6,414,587
Cash, end of period 5,755,972 915,252 2,190,722 2,731,979
Supplemental disclosure of cash flow information        
Cash paid for interest 62,521 168,038 174,104 168,038
Other non-cash investing and financing activities        
Common shares issues for earnout consideration 935,618 935,618
Modification of notes payable and warrants 217,255  
Recognition of derivative liability for warrants and preferred share conversion feature issued $ 2,013,636    
Shares returned to treasury 30,742    
Financed equipment   433,112
Non-cash note repayment   50,423
Reclass of accrued interest     89,089
Related party note issued in exchange for crypto currency     405,650
Related party note additions     245,050
Common shares issued for trade payables     368,142
Resale of note payable to related party   350,000 472,000
Conversion of convertible debentures and derivatives     11,400,078 7,083,853
Recognition of derivative liability for warrants issued     1,108,818 1,230,226
Acquisition of remaining interest in Aya Biosciences     3,649,489
Assumption of lease liability in exchange for right of use asset     268,129
Stock payable     1,900,000
Acquired licenses held for sale     1,445,483
Discount recognized on note payable